Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

17%

1 trials in Phase 3/4

Results Transparency

25%

1 of 4 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

N/A

4(80.0%)

Phase 4

1(20.0%)

5Total

N/A(4)

Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials

NCT03862196Not ApplicableUnknown

Efficacy of SMS to Improve Early Retention in HIV Care for PLWH in Lima

Role: lead

NCT03010020Not ApplicableCompleted

STI Screening as a Combined HIV Prevention Platform for MSM in Peru

Role: collaborator

NCT01760057Not ApplicableCompleted

Evaluating the Effect of a Novel Web-based Intervention to Increase HIV Testing in Men Who Have Sex With Men

Role: collaborator

NCT00925288Phase 4Completed

Acceptability of Human Papillomavirus (HPV) Vaccine in Female Sex Workers

Role: collaborator

NCT01279005Unknown

Risk Taking Behaviour in MSM and the Denial of Sexually Transmitted Diseases and HIV

Role: collaborator

NCT00751192Not ApplicableCompleted

Effect of an Online Video-Based Intervention to Increase HIV Testing in Men Who Have Sex With Men in Peru

Role: lead

All 6 trials loaded